Form 4: Alector CFO Plans Share Sale for Tax Obligations

Alector, Inc.'s CFO and Chief Business Officer, Neil Lindsay Berkley, reported a planned sale of 29,649 common shares to cover tax obligations related to RSU vesting.

Summary

• Neil Lindsay Berkley, CFO & Chief Business Officer of Alector, Inc., reported a planned sale of common stock.
• The transaction involves 29,649 shares of Alector Common Stock.
• The shares are planned to be sold on March 2, 2026, at a weighted average price of $2.1233 per share.
• The sale is intended to satisfy tax obligations arising from the vesting of restricted stock units (RSUs).
• This transaction is being made pursuant to a Rule 10b5-1 trading plan.
• Following this planned transaction, Berkley will beneficially own 344,660 shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it's an insider sale, the stated purpose of covering tax obligations for RSU vesting under a 10b5-1 plan makes it a routine administrative action rather than a signal of management sentiment.

Positives

• The sale is explicitly for tax obligations related to RSU vesting, indicating a non-discretionary reason rather than a lack of confidence in the company.
• The transaction is part of a Rule 10b5-1 plan, which provides an affirmative defense against insider trading allegations, demonstrating adherence to compliance.

Negatives

• A significant sale of 29,649 shares by a key executive, even for tax purposes, reduces their direct equity stake in the company.

Future Outlook

The filing indicates a pre-planned transaction for March 2, 2026, under a Rule 10b5-1 plan, suggesting a structured approach to managing executive compensation and tax liabilities.

Industry Context

StockSavvy.ai notes that planned sales by executives to cover tax obligations upon RSU vesting are a common and routine occurrence in the biotechnology and pharmaceutical sectors, where equity compensation is a significant component of executive pay. Such transactions are generally not indicative of a change in management's outlook on the company's prospects, especially when executed under a Rule 10b5-1 plan.

Comparison to Industry Standards

• The use of a Rule 10b5-1 plan for executive stock sales is a standard corporate governance practice, aligning with best practices seen at companies like Biogen (BIIB) or Gilead Sciences (GILD) for managing insider transactions transparently.
• Sales to cover tax liabilities upon RSU vesting are a common mechanism for executives across various industries, including tech companies like Apple (AAPL) or Microsoft (MSFT), to manage personal tax burdens without implying a lack of confidence in the company's future.

Stakeholder Impact

• Shareholders: A slight reduction in direct insider ownership, but the reason (tax obligations) mitigates concerns about management confidence.
• Employees: No direct impact on employees.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders.

Key Dates

Recommendation

The transaction is a routine, pre-planned sale by an executive to cover tax obligations from RSU vesting. It does not signal a change in the company's fundamentals or management's long-term outlook, thus warranting no change to an existing 'hold' position based solely on this filing.

Keywords

Alector, ALEC, Form 4, Insider Trading, Stock Sale, CFO, Restricted Stock Units, RSU, Tax Obligations, 10b5-1 Plan, Beneficial Ownership